abc.net.au
Jul 18, 2008
PETER CAVE: Malaria infects up to half a billion people each year and kills more than a million, most of them in the developing world. Now the former US president, Bill Clinton, has unveiled a deal with six Chinese and Indian companies to cut a key malaria drug's price by one third, and reduce its price volatility. Aid organisations have welcomed the news, but say they wish that prices could be slashed for other drugs as well. Timothy McDonald reports. TIMOTHY MCDONALD: Treatment options for malaria are nothing new, but the disease primarily affects the poor and the latest drugs are often beyond their financial reach. Now a number of companies hope to bring artemisinin-based drugs significantly cheaper. Murali Sama from Ipca Pharmaceuticals in India says his company will see reduced profits, but it is able to help. MURALI...
[read full story]